drugset / Trial / NCT01206582
A Pilot Study of Hemin Therapy for Gastroparesis (Diabetes Mellitus)
Phase 2
Completed
20 enrolled
Mayo Clinic
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · collabRECORDATI GROUP · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is designed to learn if hemin can increase the production of heme oxygenase 1 and improve gastric (stomach) emptying and symptoms in diabetic patients with slow gastric emptying (gastroparesis).
Timeline
- Start
- 2010-05
- Primary completion
- 2014-12
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Hemin | Unknown | 3 mg/kg | Intravenous |